FDA filing guidance to add sterilization step for approved drug

#1
Dear Colleagues,
Can anyone point me to the FDA guidance as to what type of filing would be required if a sterilization step is added to an approved drug. Can this be filed as a PAS or would this require a new drug application?
Thank you
 
Elsmar Forum Sponsor

v9991

Trusted Information Resource
#2
i assume that you are intending to add "sterilization step" to approved product. i.e,.,
* either you were receiving pre-sterilized material which is now intended to be done inhouse.
* or you were doing sterilization as outsourced activity, which is now intended to be done inhouse.

First :- do you have the sterilization step existing in your facility, and
Second :whether it is prior-approved by agency.
Third :- whether the sterilization has been part of the earlier approved-submission.

- in either case, this will lead to major changes in the process. ( of managing materials or manufacturing process)
Hence this should be categorized as prior-approval changes.


Here's few reference.s,
Changes to an Approved NDA or ANDA
4. Transfer of the manufacture of an aseptically processed sterile drug substance or aseptically processed sterile drug product to (1) a newly constructed or refurbished aseptic processing facility or area or (2) an existing aseptic processing facility or area that does not manufacture similar (including container types and sizes) approved drug products.
would be transferring the manufacture of a lyophilized drug product to an existing aseptic process area where no approved lyophilized drug products are manufactured or where the approved lyophilized drug products being manufactured have different container types and/or sizes than the container of the drug product being transferred. See section VI.C.1.b for recommendations for other manufacturing site changes relating to aseptically processed sterile drug substance or aseptically processed sterile drug product. 5. Transfer of the manufacture of a finished drug product sterilized by terminal processes to a newly constructed facility at a different manufacturing site. Once this change has been approved, subsequent site changes to the facility for similar drug product types and processes may be submitted as a changes-being-effected-in-30-days supplement (see section VI.C.1.a).
Changes to an Approved NDA or ANDA
Q12: What is the recommended reporting category for the addition of a new aseptic filling line for sterile products?
A12: The addition of a new aseptic filling line should be reported in a prior approval supplement (section VI.B.4).
Q3: The guidance recommends notification in an annual report for a change in the container closure system for a nonsterile drug product, based on a showing of equivalency to the approved system under a protocol approved in the application or published in an official compendium. Does “protocol” refer to a comparability protocol or the approved stability protocol?
A3: With respect to the guidance, the term protocol refers to tests, validation studies, and acceptable limits to be achieved to demonstrate the absence of adverse effect on the identity, strength, quality, purity, and potency of the drug from specific types of changes. This type of protocol is often referred to as an equivalency protocol or comparability protocol. The approved stability protocol may be one part of the comparability/equivalency protocol to help demonstrate the absence of an adverse effect.
 
#3
Thank you v9991 for the references.
Please see below responses to the questions:
First :- do you have the sterilization step existing in your facility, and
Second :whether it is prior-approved by agency.
Third :- whether the sterilization has been part of the earlier approved-submission.
First - No sterilization in current facility
Second: Not prior-approved by agence
Third: Not part of approved submission
 

v9991

Trusted Information Resource
#4
Thank you v9991 for the references.
Please see below responses to the questions:

First - No sterilization in current facility
Second: Not prior-approved by agence
Third: Not part of approved submission
Hence therefore this ought to be an submission prior-approval before you put it on market...

independent of above opinion, what is the material-category you are dealing with because, even if its not part of your submission, the sterilization might have been part of the supplier's submission package; an description of situation could throw more light...on specifics... Again I don't see it can impact on above opinion.
 
Last edited by a moderator:

drhkp

Registered
#5
Hence therefore this ought to be an submission prior-approval before you put it on market...

independent of above opinion, what is the material-category you are dealing with because, even if its not part of your submission, the sterilization might have been part of the supplier's submission package; an description of situation could throw more light...on specifics... Again I don't see it can impact on above opinion.
Good idea, let me inquire into the supplier submission. Thank you for your help and guidance.
 

v9991

Trusted Information Resource
#6
Thank you v9991 for the references.
Please see below responses to the questions:

First - No sterilization in current facility
Second: Not prior-approved by agence
Third: Not part of approved submission
as there is no sterilization in current facility, the approval of anda would be subject to that critical addition i.e., critical to product and critical to facility related point ==> hence prior approval.
again, i am not aware of any exception for treating the sterilization as anything other than critical operation., hence it would trigger an prior-inspection and prior-submission before approval. ( your specific instance has to trigger such an exception!)
 
#7
as there is no sterilization in current facility, the approval of anda would be subject to that critical addition i.e., critical to product and critical to facility related point ==> hence prior approval.
again, i am not aware of any exception for treating the sterilization as anything other than critical operation., hence it would trigger an prior-inspection and prior-submission before approval. ( your specific instance has to trigger such an exception!)
Checked with suppliers they do not have sterilization step either. In my mind, at a minimum it will be a PAS.
 

v9991

Trusted Information Resource
#8
Checked with suppliers they do not have sterilization step either. In my mind, at a minimum it will be a PAS.
it has to be prior-approval supplement; however, this is leading to another question, is how was process meeting the 'sterility' criteria, unless it is newly introduced target?
 
#9
it has to be prior-approval supplement; however, this is leading to another question, is how was process meeting the 'sterility' criteria, unless it is newly introduced target?
There was no sterility criteria, new process step to be added.
 
Thread starter Similar threads Forum Replies Date
S FDA eSubmitter Medical Device Software 510k Filing Other US Medical Device Regulations 8
O Clarifying FDA definition of "finished device" and “capable of functioning” 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 2
A FDA guidance on non-sterile Medical Device Packaging Medical Device and FDA Regulations and Standards News 4
JoCam FDA Registration for Sub-contract manufacturers Medical Device and FDA Regulations and Standards News 2
M FDA News FDA Releases Draft Guidance Clarifying Application of ISO 10993-1 Biocompatibility Standard Medical Device and FDA Regulations and Standards News 0
M Is IEC 60601-1-2 required by FDA for all electronic medical devices? IEC 60601 - Medical Electrical Equipment Safety Standards Series 1
E Contract manufacturer FDA requirements foreign company US Food and Drug Administration (FDA) 6
P Choice of FDA reviewer US Food and Drug Administration (FDA) 6
J Is Device Tracking Card an actual requirement under FDA regulation? Other US Medical Device Regulations 0
T Definition Human Use (FDA) Definitions, Acronyms, Abbreviations and Interpretations Listed Alphabetically 7
K FDA 510k electrosurgery 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 0
J Leveraging FDA 510k Clearance for International Registrations Other Medical Device Regulations World-Wide 2
shimonv FDA News FDA guidance on Multiple Function Device Products (8/2020) Other US Medical Device Regulations 1
N FDA UDI - Label vs. Labeling - Does the insert need to include UDI? Other US Medical Device Regulations 0
J FDA notification of address change US Food and Drug Administration (FDA) 2
N Usability testing required for FDA IDE (investigational device exemption)? Human Factors and Ergonomics in Engineering 3
A FDA Class Classification for a cabinet 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 1
L FDA Biocompatibility Requirements - Transitory Contact Other US Medical Device Regulations 1
Edward Reesor FDA DM and /or Class I Life Saving US Food and Drug Administration (FDA) 0
Watchcat FDA will not tolerate fraud…meaning what, exactly? Other US Medical Device Regulations 6
K FDA Premarket Cybersecurity Guidance - 4 questions Other US Medical Device Regulations 5
gunnyshore Form FDA 3500A MedWatch eSubmitter 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 5
Watchcat FDA Webinar Series - N95 Respirators Other US Medical Device Regulations 0
M Off-Label Use - Clarification of FDA Policy US Food and Drug Administration (FDA) 1
J Sub-supplier change from manual to automated process - same specs - Report to FDA? 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 2
C FDA Establishment registration - Buying some medical devices from another manufacturer Medical Device and FDA Regulations and Standards News 5
I How to classify a medical device based on FDA? 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 3
dinaroxentool Question about FDA Classification of a Device 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 3
S The US FDA requirements on Disposal of a medical device US Food and Drug Administration (FDA) 1
S FDA Requirements for Medical Device Label Reconciliation 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 1
S What is considered a "core algorithm"? (From an FDA guidance document) Medical Information Technology, Medical Software and Health Informatics 4
B FDA-Medical Device Reporting (MDR )procedure compliant with 21CFR section 803 US Food and Drug Administration (FDA) 0
Stoic Are any medical device companies using the 2011 FDA process validation guidance instead of GHTF/SG3/N99-10:2004? 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 1
D ISO 13485, FDA 21 CFR 820 and Auditing the Accounting Department ISO 13485:2016 - Medical Device Quality Management Systems 5
S FDA's E submitter - For clinical electronic thermometer Medical Device and FDA Regulations and Standards News 6
J FDA wants electrical safety testing on battery powered medical device US Food and Drug Administration (FDA) 11
A FDA and NB audit of Engineering Drawings in DHF and DMR. Medical Device and FDA Regulations and Standards News 1
D FDA De Novo Cover Letter - What is expected US Food and Drug Administration (FDA) 3
Ed Panek 21 CFR Part 820 - FDA Label Requirements 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 8
J Mislabeling - Consider this an FDA notified recall? CFR 806.10 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 2
O Hospital-Developed, In-House Device - FDA Clearance? Other US Medical Device Regulations 19
D FDA Approved Class II Medical Device? Other US Medical Device Regulations 11
R When does the FDA consider a component a medical device? 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 17
N Risk Management besides mandated FDA requirements 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 1
M Informational US FDA – Ear, Nose, and Throat Devices; Classification of the Self-Fitting Air-Conduction Hearing Aid Medical Device and FDA Regulations and Standards News 0
L UDI Requirments Gap Analysis - EU MDR vs FDA CFR EU Medical Device Regulations 8
M Informational US FDA – Modifications to the List of Recognized Standards, Recognition List Number: 052 Medical Device and FDA Regulations and Standards News 0
M Informational US FDA Draft Guidance – Breast Implants – Certain Labeling Recommendations to Improve Patient Communication Medical Device and FDA Regulations and Standards News 0
M Looking for third party reviewers for FDA submissions US Food and Drug Administration (FDA) 2
M Informational Work in progress at the FDA for biological evaluation – Color Hazard and RISk calculator (CHRIS) Medical Device and FDA Regulations and Standards News 0

Similar threads

Top Bottom